Literature DB >> 21246710

Effect of anesthesia carrier gas on in vivo circulation times of ultrasound microbubble contrast agents in rats.

Lee Mullin1, Ryan Gessner, James Kwan, Mehmet Kaya, Mark A Borden, Paul A Dayton.   

Abstract

PURPOSE: Microbubble contrast agents are currently implemented in a variety of both clinical and preclinical ultrasound imaging studies. The therapeutic and diagnostic capabilities of these contrast agents are limited by their short in-vivo lifetimes, and research to lengthen their circulation times is on going. In this manuscript, observations are presented from a controlled experiment performed to evaluate differences in circulation times for lipid shelled perfluorocarbon-filled contrast agents circulating within rodents as a function of inhaled anesthesia carrier gas.
METHODS: The effects of two common anesthesia carrier gas selections - pure oxygen and medical air were observed within five rats. Contrast agent persistence within the kidney was measured and compared for oxygen and air anesthesia carrier gas for six bolus contrast injections in each animal. Simulations were performed to examine microbubble behavior with changes in external environment gases.
RESULTS: A statistically significant extension of contrast circulation time was observed for animals breathing medical air compared to breathing pure oxygen. Simulations support experimental observations and indicate that enhanced contrast persistence may be explained by reduced ventilation/perfusion mismatch and classical diffusion, in which nitrogen plays a key role by contributing to the volume and diluting other gas species in the microbubble gas core.
CONCLUSION: Using medical air in place of oxygen as the carrier gas for isoflurane anesthesia can increase the circulation lifetime of ultrasound microbubble contrast agents.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21246710      PMCID: PMC3341737          DOI: 10.1002/cmmi.414

Source DB:  PubMed          Journal:  Contrast Media Mol Imaging        ISSN: 1555-4309            Impact factor:   3.161


  31 in total

1.  Mechanisms of contrast agent destruction.

Authors:  J E Chomas; P Dayton; J Allen; K Morgan; K W Ferrara
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2001-01       Impact factor: 2.725

2.  A method for radiation-force localized drug delivery using gas-filled lipospheres.

Authors:  Michaelann J Shortencarier; Paul A Dayton; Susannah H Bloch; Patricia A Schumann; Terry O Matsunaga; Katherine W Ferrara
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2004-07       Impact factor: 2.725

Review 3.  Contrast ultrasound: general principles and veterinary clinical applications.

Authors:  Stefanie Ohlerth; Robert T O'Brien
Journal:  Vet J       Date:  2007-04-06       Impact factor: 2.688

4.  Inhaled gases affect the ultrasound contrast produced by Albunex in anesthetized dogs.

Authors:  J H Wible; J K Wojdyla; G L Bales; W N McMullen; E A Geiser; D D Buss
Journal:  J Am Soc Echocardiogr       Date:  1996 Jul-Aug       Impact factor: 5.251

5.  Myocardial ischemic memory imaging with molecular echocardiography.

Authors:  Flordeliza S Villanueva; Erxiong Lu; Shivani Bowry; Sevgi Kilic; Eric Tom; Jianjun Wang; Joan Gretton; John J Pacella; William R Wagner
Journal:  Circulation       Date:  2007-01-08       Impact factor: 29.690

Review 6.  Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery.

Authors:  Jean G Riess
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2005

7.  Growth and dissolution of an encapsulated contrast microbubble: effects of encapsulation permeability.

Authors:  Kausik Sarkar; Amit Katiyar; Pankaj Jain
Journal:  Ultrasound Med Biol       Date:  2009-08       Impact factor: 2.998

8.  Controllable microfluidic synthesis of multiphase drug-carrying lipospheres for site-targeted therapy.

Authors:  Kanaka Hettiarachchi; Shirley Zhang; Steven Feingold; Abraham P Lee; Paul A Dayton
Journal:  Biotechnol Prog       Date:  2009 Jul-Aug

9.  Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents.

Authors:  Susanne M Stieger; Paul A Dayton; Mark A Borden; Charles F Caskey; Stephen M Griffey; Erik R Wisner; Katherine W Ferrara
Journal:  Contrast Media Mol Imaging       Date:  2008 Jan-Feb       Impact factor: 3.161

10.  Microbubble dissolution in a multigas environment.

Authors:  James J Kwan; Mark A Borden
Journal:  Langmuir       Date:  2010-05-04       Impact factor: 3.882

View more
  41 in total

1.  Effect of surface architecture on in vivo ultrasound contrast persistence of targeted size-selected microbubbles.

Authors:  Cherry C Chen; Shashank R Sirsi; Shunichi Homma; Mark A Borden
Journal:  Ultrasound Med Biol       Date:  2012-03       Impact factor: 2.998

2.  Use of an Integrated Low-Flow Anesthetic Vaporizer, Ventilator, and Physiological Monitoring System for Rodents.

Authors:  Krista Bigiarelli; Luke E Schepers; Arvin H Soepriatna; Dave FitzMiller; Craig J Goergen
Journal:  J Vis Exp       Date:  2020-07-09       Impact factor: 1.355

3.  Design of ultrasonically-activatable nanoparticles using low boiling point perfluorocarbons.

Authors:  Paul S Sheeran; Samantha H Luois; Lee B Mullin; Terry O Matsunaga; Paul A Dayton
Journal:  Biomaterials       Date:  2012-01-29       Impact factor: 12.479

4.  Phase-shift perfluorocarbon agents enhance high intensity focused ultrasound thermal delivery with reduced near-field heating.

Authors:  Linsey C Phillips; Connor Puett; Paul S Sheeran; G Wilson Miller; Terry O Matsunaga; Paul A Dayton
Journal:  J Acoust Soc Am       Date:  2013-08       Impact factor: 1.840

Review 5.  Evaluating the safety profile of focused ultrasound and microbubble-mediated treatments to increase blood-brain barrier permeability.

Authors:  Dallan McMahon; Charissa Poon; Kullervo Hynynen
Journal:  Expert Opin Drug Deliv       Date:  2019-01-29       Impact factor: 6.648

6.  High-intensity focused ultrasound sonothrombolysis: the use of perfluorocarbon droplets to achieve clot lysis at reduced acoustic power.

Authors:  Daniel Pajek; Alison Burgess; Yuexi Huang; Kullervo Hynynen
Journal:  Ultrasound Med Biol       Date:  2014-07-09       Impact factor: 2.998

7.  Acoustic Droplet Vaporization in Acoustically Responsive Scaffolds: Effects of Frequency of Excitation, Volume Fraction and Threshold Determination Method.

Authors:  Mitra Aliabouzar; Xiaofang Lu; Oliver D Kripfgans; J Brian Fowlkes; Mario L Fabiilli
Journal:  Ultrasound Med Biol       Date:  2019-09-25       Impact factor: 2.998

8.  MR-Guided Delivery of Hydrophilic Molecular Imaging Agents Across the Blood-Brain Barrier Through Focused Ultrasound.

Authors:  Raag D Airan; Catherine A Foss; Nicholas P K Ellens; Yuchuan Wang; Ronnie C Mease; Keyvan Farahani; Martin G Pomper
Journal:  Mol Imaging Biol       Date:  2017-02       Impact factor: 3.488

9.  Novel method for the formation of monodisperse superheated perfluorocarbon nanodroplets as activatable ultrasound contrast agents.

Authors:  C de Gracia Lux; A M Vezeridis; J Lux; A M Armstrong; S R Sirsi; K Hoyt; R F Mattrey
Journal:  RSC Adv       Date:  2017-10-16       Impact factor: 3.361

10.  Toward ultrasound molecular imaging with phase-change contrast agents: an in vitro proof of principle.

Authors:  Paul S Sheeran; Jason E Streeter; Lee B Mullin; Terry O Matsunaga; Paul A Dayton
Journal:  Ultrasound Med Biol       Date:  2013-02-27       Impact factor: 2.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.